Ivan Bergstein, Chief Executive Officer at STEMLINE THERAPEUTICS INC (STML), sold 13,594 shares at $16.56 ($225K) on 2018-03-07, disclosed to the SEC on 2018-03-09.
Seasonal sale ($225k) by Chief Executive Officer — this insider has traded STML in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.56 | 6,797 | $113K | 50.0% |
| 2 | $16.56 | 6,797 | $113K | 50.0% |
| Total | $16.56 avg | 13,594 | $225K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $316K | — | Filing → |
| STML | SELL | 2020-01-03 | $987K | — | Filing → |
| STML | SELL | 2019-08-16 | $1.0M | — | Filing → |